GE Marquette Medical Systems has garnered two awards from research firm Frost & Sullivan for its use of market research: the Competitive Strategy Award and the Product Line Strategy Award.These awards are based on independent research and analysis of
GE Marquette Medical Systems has garnered two awards from research firm Frost & Sullivan for its use of market research: the Competitive Strategy Award and the Product Line Strategy Award.
These awards are based on independent research and analysis of companies in the healthcare industry. GE Marquette stood out as a sole-source provider of clinical information systems and devices for patient monitoring and cardiology, and the company has been recognized for forming Web-based alliances to keep it competitive, according to Mahpara Qureshi, Frost & Sullivan industry analyst.
GE Marquettes alliances with companies that produce technology complementary to its own products include Draeger, Critikon, NEC Medical Systems, CardioDynamics, Novametrix, Micro Medical, Data Critical, and Aspect Medical Systems. Wisconsin-based GE Marquettes products focus on diagnostic cardiology, patient monitoring, and clinical information systems.
Recently, GE Marquette signed a three-year contract with Consorta Catholic Resource Partners to provide patient monitoring systems and services to its 900 hospitals and clinics around the world.
Under this agreement, GE Marquette will be a preferred provider of patient monitoring solutions, including the Solar family of advanced vital sign monitoring systems, the Eagle model configured monitors, and the portable Dash monitor, which supports continuous patient monitoring during an ambulance or aircraft ride.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.
CT Perfusion Study Shows Enhanced Detection of Medium Vessel Occlusions with Emerging AI Software
May 21st 2025The Rapid CTP AI software offered 23 percent greater detection of medium vessel occlusions in comparison to the Viz CTP AI software, according to research presented at the European Stroke (Organization) Conference (ESOC).